Summary
Writing in the BMJ, Kinnon MacKinnon, Pablo Expósito-Campos and W Ariel Gould argue that people who stop or reverse a gender transition have been ignored by research and care, partly because the topic has become political. Drawing on a few small studies of volunteers, they describe detransitioners as varied, but often female and young when they transitioned. Their reasons range from a change in identity and gender distress that didn't go away, to health worries and discrimination. Many have medical and mental health needs that aren't being met. The authors recommend following patients for at least 5 to 10 years and not assuming that people who drop out of studies (over 30% in some) are doing well. It is a sensible research plan, not new evidence. There was no formal search, and some claims rest on news reports or the authors' own studies.
Key findings
- This is an analysis article, not a full review of the research: it summarises a few early studies and makes recommendations, with no new data.
- The studies cited (for example an online survey of 237 detransitioners, 92% female, and a Canadian interview study of 28) suggest many detransitioners were born female and transitioned before age 25.
- Reasons for detransition include a change in identity, gender distress that transition didn't fix, physical or mental health worries, discrimination, and distress caused by the treatment itself ('reverse dysphoria').
- After detransition, many people describe ongoing gender distress, regret, grief or mixed feelings, losing support from LGBTQ+ friends, and avoiding doctors for fear of being judged.
- The authors say following people for 1 to 2 years is too short, because detransition usually happens several years after treatment. They recommend at least 5 to 10 years.
- They warn that over 30% of patients drop out of some gender care studies, and that researchers should not assume these people still identify as trans or have no further needs.
- They recommend choosing study groups by the treatment people received rather than their current identity, using the words 'detrans' and 'detransition', and building non-judgemental detransition care into gender services.
Abstract
Kinnon MacKinnon and colleagues call for robust, sensitive research to inform comprehensive gender care services for people who detransition
Conclusion
Rigorous and nuanced detransition research is indispensable. Investigating the experiences of people who detransition will provide a better understanding of the development of gender identity, as well as all health and psychosocial outcomes following gender care. This aligns with priorities identified by trans health experts. Unfortunately, ongoing debates and politicisation of gender care have resulted in the depiction of trans and detrans people as completely distinct groups with divergent needs and experiences, and who are doomed to conflict. However, we believe that trans and detrans people are more similar than different, and that detransition research holds value for advancing the healthcare of all those who transition, and for responsibly moving gender care research and practice forward.